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Preimplantation tissue typing has been proposed as a method for creating a tissue matched child that can
serve as a haematopoietic stem cell donor to save its sick sibling in need of a stem cell transplant. Despite
recent promising results, many people have expressed their disapproval of this method. This paper
addresses the main concerns of these critics: the risk of preimplantation genetic diagnosis (PGD) for the
child to be born; the intention to have a donor child; the limits that should be placed on what may be done
to the donor child, and whether the intended recipient can be someone other than a sibling. The author will
show that these concerns do not constitute a sufficient ground to forbid people to use this technique to save
not only a sibling, but also any other loved one’s life. Finally, the author briefly deals with two alternative
scenarios: the creation of a human leukocyte antigen (HLA) matched child as an insurance policy, and the
banking of HLA matched embryos.
1. PREIMPLANTATION GENETIC DIAGNOSIS IN
CONJUNCTION WITH HLA-TYPING
Preimplantation genetic diagnosis (PGD) has been used to
enable families to have a child that is a tissue match for an
existing sick sibling in need of an allogeneic haematopoietic
stem cell (HSC) transplantation. HSCs are blood forming cells
found in the bone marrow, the peripheral blood, and the
umbilical cord blood. For several lethal malignant disorders
and also for some non-malignant disorders bone marrow or
blood cell transplantations are currently the only therapeutic
approach.1 The success of a transplant depends on how well
the human leukocyte antigen (HLA) types of the donor and
recipient match.i
A transplant from an HLA identical sibling is associated
with a much higher success rate than a transplant from
alternative donors.2 Since all humans inherit half of their
HLA type from their mother and the other half from their
father, each sibling has a one in four chance of being HLA
identical to one of his siblings. Given the current size of the
average family in Western countries, the chance of having an
HLA identical sibling is no more than 15%.3
The use of PGD is not a necessary condition for creating
‘‘HLA matched donor children’’. Before the routine use of
PGD in assisted reproduction technologies (ART), there had
been several cases in which a couple had had one or more
children, through natural reproduction or IVF, in the hope
that those children or one of them would be an HLA match
for an existing child in need of a HSC transplant. Two such
cases were the well publicised Ayala case in 19934 and the
less well known Curry case in 1991.ii Some sought prenatal
diagnosis and were prepared to terminate their pregnancy if
the fetus was not a match.5
Preimplantantion genetic diagnosis for HLA testing has
been proposed as a superior method for creating a tissue
matched child that can donate stem cells to its sick sibling.6
The main advantage of this method is that it provides genetic
information about embryos prior to implantation, so it is
possible to ensure that only those embryos that are a tissue
match are transferred to the mother’s uterus. The couple can
thus avoid the difficult decision of either terminating the
pregnancy if the fetus is not a match or of extending the
family, in the hope that the next child will have the desired
HLA type.
In May 2004, a team headed by Anver Kuliev and Yuri
Verlinsky, at the Reproductive Genetics Institute of Chicago,
reported the birth of five healthy children from five different
couples, created to serve as HSC donors for their older
siblings affected with leukaemia, or diamond blackfan
anaemia (DBA),7 a rare form of anaemia where the bone
marrow produces few, or no, red blood cells and which
results in severe deterioration of normal life sustaining
functions. Haematopoietic stem cell transplantation is the
only possible cure. Since the leukaemia and the DBA in the
affected siblings are sporadic, the matched children were not
at risk from the same disease. This means that PGD was used
solely for HLA typing, and not as a diagnostic technique to
detect genetic diseases, for which it is normally used. One
sibling with DBA received transplantation and is no longer
dependent on transfusions of red blood cells, whereas the
others are in preparation for transplantation or are in
remission.7
In March, the Belgian team led by Van de Velde reported
the development of a new HLA typing technique which
Abbreviations: DBA, diamond blackfan anaemia; HLA, human
leukocyte antigen, HSC, haematopoietic stem cell; PGD, preimplantation
genetic diagnosis
iA person’s human leukocyte antigen type is determined by her antigen
pattern, that is, the markers on the surface of body cells and tissues. They
are used by the immune system to distinguish one’s own body cells and
tissues from foreign ones.
ii In the Curry case a couple in the US had a daughter, Natalie Curry,
with Fanconi’s anaemia. The couple decided to have another child in the
hope that it would be a tissue match for Natalie. The woman became
pregnant, but the fetus miscarried. After one month she was pregnant
again, and a healthy baby, Audrey, was born. Unfortunately, Audrey
was an unsuitable donor. Within 12 weeks the woman was pregnant
again. Emily was born healthy and was a match. Twenty months after
Emily’s birth, cord blood was transplanted into her sister, who was then
four years old. Two years later Natalie was cured.4
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would considerably speed up the process of HLA typing.8 The
sooner a donor match is found, the greater the success rate of
the HSC transplant in the sick sibling. The study aimed at
conceiving tissue donors for children affected with B-
thalassaemia, but the method could potentially be used for
other conditions as well where the selection of an HLA
identical embryo to create a stem cell donor may be
requested, including other types of cancer and other disorders
of the blood cell lineage (Verlinsky et al,7 p 2082). For a list of
diseases treated by HSC transplants see the webpage
developed by the Umbilical Cord Blood Education Alliance.9
Despite these promising results, however, many people
have expressed their disapproval of the use of preimplanta-
tion tissue typing to have a child that can save a sick sibling.
I will address some of the main concerns of these critics
and show that they do not constitute a sufficient ground to
forbid people to use this technique to save the life of either a
sibling, or of any other loved one.
2. THE RISKS OF PGD FOR THE CHILD TO BE BORN
Preimplantation genetic diagnosis is an established method
for the diagnosis of genetic diseases, the aim of which is to
prevent the implantation of affected embryos.10 Many
defenders of PGD for selection against genetic diseases are,
however, opposed to PGD solely for HLA typing. They argue
that an embryo and the person it will become should be
exposed to the risks of PGD only if the embryo/that person is
likely to derive enough benefit to outweigh these risks.11
These risks are the as yet unknown long term effects of PGD
resulting from the extraction of one or two cells from the
early embryo. The underlying reasoning is that when PGD is
used to test for genetic diseases that testing is done in the best
interests of the embryo or the person it will become, whereas
when PGD is used solely for tissue typing, the only benefit is
for the existing sick child. Before the recent extension of the
UK Human Fertilisation and Embryology Authority’s policy
on tissue typing,12 the HFEA’s chair, Suzi Leather, formulated
it as follows: ‘‘PGD can secure an outcome, which is much
better than the horrible death say, of an infant with Tay
Sachs condition. Clearly then the resulting child benefits
from the PGD to the extent that it owes its serious-disorder-free
life to PGD [author’s italics]. But an intervention which
imposes risks without benefits, or where the benefits accrue
to another person, is very different.’’13
This way of stating the objection is problematic. It is
misleading to say that the child owes its ‘‘serious-disorder-
free’’ life to PGD. The child without Tay Sachs owes its life to
PGD, in the same way as any other child selected following
PGD for whatever reason owes its life to PGD. It is not as if
the same child without PGD would have been affected by the
disease. Preimplantation genetic diagnosis is not a cure, it is a
selection procedure. An embryo is selected because of genetic
characteristics it already had.14
How then can PGD benefit children resulting from this
procedure? For those who believe it is better to exist than not
to exist (except if your life is so bad that it is not worth
living), the only conceivable benefit of PGD for the resulting
child is its existence, rather than a ‘‘serious-disorder-free’’
existence. Without PGD it would probably not have existed at
all. The parents would not have had this particular child. For
those who do not believe existence is a benefit, none of the
children who have come into the world after PGD have
directly benefited from PGD. Consequently, regardless of
whether you think coming into existence is a benefit or
not, PGD does not benefit the child in the sense that it
prevents the child from having a serious disease. The
argument expressed by Suzi Leather does not hold good.
Will the resulting child be harmed by PGD? We could
say that one part of the procedure—the extraction of the
cells—might harm the child, but PGD as a whole might
nevertheless not harm the child if it was a necessary condition
for the child’s existence. This does not mean that the child
could not have a complaint about the procedure. However, a
child resulting from PGD for tissue typing has no more
grounds for complaint about possible side effects than a child
resulting from PGD for diagnosis of a genetic disease, given
that in both cases PGD was a necessary condition for the
children to exist. This has an important implication.
In the case of PGD for HLA typing, PGD is carried out for a
clearly person affecting reason, namely saving an existing
person—the sick sibling—whereas in the case of PGD for the
selection against genetic disease, PGD is carried out for a
mainly non-person affecting reason, namely the creation of a
new person without a genetic disease as opposed to the
creation of another new person with a genetic disease. (See
the non-identity problem developed by Derek Parfit.15) Of
course we could say there will also be person affecting
reasons for the latter—namely to benefit parents and
society—but these kinds of person affecting reasons might
also operate in the former case. The important point is that in
the case of PGD for HLA typing there is an extra sort of person
affecting reason for doing PGD, namely to save the sick
child.iii
In my opinion, this makes the moral case for PGD for HLA
typing even stronger than the moral case for PGD for
selection against genetic diseases.
If one accepts the possible risks of PGD for the benefit of
people who want a child, one should certainly accept these
risks for the benefit of parents who want a child and for the
benefit of a sick child in need of a transplant.
In both cases, however, we should only go ahead with the
procedure if we think the health risks are minimal. It seems
incoherent to me to treat a sick, suffering child by bringing
new suffering into the world. The crucial question is what
amount of suffering we can risk inflicting on one person to
alleviate the suffering of another person. One strategy, and I
think this is a very reasonable one, is to look at what is
generally accepted in society, that is, the risk we accept now
in sexual reproduction. Since the introduction of PGD in 1990
more than 1000 children have been born as a result of the
procedure.16 Current studies indicate that embryo biopsy does
not increase the incidence of major malformations in the
children compared to IVF or intracytoplasmic sperm injection
(ICSI) children, or to figures from population registers.17 In
order to introduce a control mechanism for risk assessment,
families should be encouraged to participate in follow up
studies.
3. THE INTENTION TO HAVE A DONOR CHILD
It is, however, precisely this person affecting reason that is
the main cause for concern for the opponents of preimplan-
tation tissue typing to create a donor child. Richard
Nicholson, editor of the Bulletin of Medical Ethics, says: ‘‘We
are not creating this saviour sibling to be a child in its own
right. We have created it—designed it—to be a source of
spare parts for an existing child.’’18 Nicholson continues:
‘‘Where do we draw a moral distinction between slaver-
y…and creating what I prefer to call slave siblings’’.18 Suzi
Leather says we might equally call them ‘‘spare part sisters’’
or ‘‘bred to order brothers’’.
These statements are problematic because they are based
on the speculative assumption that donor children, or so
called ‘‘saviour siblings’’, are created merely for instrumental
reasons—to serve as a donor for the sick sibling—and not for
their own sake. It has been argued many times before that
this line of reasoning does not hold good.3 19 20
iiiThanks to Nick Bostrom for very helpful feedback.
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First of all, parents have children for all kinds of
instrumental reasons. Results of ‘‘The Value of Children
Project’’ (in 1973, before most assisted reproduction techni-
ques were developed), coordinated by James Fawcett,
indicated that one of the advantages of childbearing most
frequently mentioned is the benefit for the husband wife
relationship. Other frequently mentioned reasons include
‘‘immortality’’ of the individual, continuity of the family
name, and the economic and psychological benefits children
provide when their parents become old.21 This is not
considered to be problematic, as long as the child is also
valued in its own right.
What does it mean, however, to be valued in your own
right? (If you are extremely rich or talented, and people
approach you because of these characteristics, does that
mean they do not value you in your own right?). Suppose we
express it differently, and situate the problem not in the
vagueness of not being valued in your own right, but rather
in terms of not being respected, loved, or taken care of in the
way people expect in given circumstances. Consider, for
example, adoption. It is generally expected—at least, in
theses times and in certain cultures—that when you make a
child, you should accept that it is your responsibility to raise
and educate it. (This is the basis of the ‘‘welfare of the child
assessment’’ in ART prescribed by the HFEA act22). In the
Netherlands, more than 70 children are put up for adoption
every year, and the rate is still increasing. Since the adoption
law came into force (1954) approximately 25 000 Dutch
children have been adopted out. The Dutch Birthmother
Foundation serves the interests of Dutch birthmothers and
aims at ‘‘breaking through the social prejudices involved in
giving up a child, discussing the alternatives to giving up a
child, bringing birthmothers into contact with each other and
giving them support, influencing the development of policy
on adopting as well as giving up a child and expressing
solidarity with birthmothers in other countries’’.23 From an
American site for birthmothers we learn that ‘‘there are many
reasons why Birthparents choose adoption: a single mother
may want her baby to have two stable parents, a couple may
feel they’re too young or don’t have the financial resources to
raise a child. Others need to complete their education or are
in the midst of career difficulties. Even married birthparents
may feel their relationship is not stable enough for a child or
they cannot care for more children.’’24 It is even stated on the
site that ‘‘Birthmothers are the generous women who have
made a choice that will enrich a child’s life and bless
adopting parents with the ultimate gift of life—to be able to
parent’’.
These claims may not represent the general opinion in
society, but they show us that in human reproduction there is
always a risk of abandonment. Moreover, the fact that
support is provided for these birthparents, instead of—for
example, punishment via imprisonment or fines, shows we
think that children put up for adoption do not face prospects
so awful that we should do everything we can to prevent that
children will be abandoned. If we accept that there is a risk of
abandonment in human reproduction, why should we forbid
people to have a child to save their pre-existing child because
of the risk of ‘‘instrumentalisation’’ and/or abandonment?
One argument could be that the risk of abandonment
would be much higher in the case of donor children because
there is a difference in intention when having these children.
The reasoning then is that, whereas—to continue the
adoption analogy—having a child by accident and adopting
it out is acceptable, the creation of a child with the intention
to use its stem cells and then to adopt it out, is something
very different, and ethically unacceptable. Many opponents
of preimplantation HLA typing argue that although the
harvesting of haematopoietic stem cells from children is
acceptable, it is wrong to create a child with this intention.
For some this is a sufficient argument to forbid preimplanta-
tion tissue typing in order to have a donor child. Others are of
the opinion that the creation of a donor child is acceptable
only if the parents wanted another child anyway: they need to
have a ‘‘genuine desire to have a child’’; their intention to
have a child should be clearly separated from the later ‘‘use’’
of the child.25 My response to this is that first of all, these
people seem to forget that plans to have children typically
change according to the circumstances and experiences of
childrearing. Secondly, it is extremely difficult, if not
impossible, to separate the reasons that lead to the concep-
tion of a child because of a ‘‘genuine desire for a child’’ from
those linked to an attempt to save another child. Moreover,
these critics mistakenly presuppose that the desire or the
intention to have a child determines the attitudes of the
parents toward the child once born. This would imply that
children conceived in order to have a brother or sister for an
already existing child would not be loved, which, fortunately,
is not the case.
If parents were to abandon the child after they had
obtained the stem cells, then, of course, it would be clear they
had created the child merely for instrumental reasons and
this would wrong the child. Firstly, such a scenario is most
implausible. The fact that these parents make so much effort
to try to save their first child suggests they are caring and
loving parents and makes it very unlikely that they will treat
the new baby as a ‘‘bred to order child’’.19 What is most
important in a parent child relationship is the love and care
inherent in this relationship. We judge people on their
attitudes toward children, rather than on their motives for
having them. Anecdotal evidence from the families who have
created a child as a tissue donor for their pre-existing sick
child indicates that these children receive all the love and
care children should get, see—for example, the article by
Jablon.26 Secondly, as pointed out before, reproduction
always involves a risk of abandonment. This is not a reason
to stop conceiving children. Moreover, we should always keep
in mind that the potential benefits for the sick child are
enormous, which could well compensate for the risks to the
future child, that is to the child to be created.
4. LIMITS: WHAT CAN BE HARVESTED FROM THE
CHILD AND FOR WHOM?
Two central concerns of opponents of preimplantation tissue
typing to create a tissue donor are the limits that should be
placed on what may be done to the donor child in order to
treat a sibling, and whether the intended recipient can be
someone other than a sibling.27
In accepting someone as an organ donor the most crucial
considerations are the seriousness of the recipient’s need, the
likelihood of avoiding serious complications for the donor,
and the quality of the donor’s consent. Of course, newborns
and small children cannot give autonomous donor consent.
To decide what can be done to a child created to serve as a
donor we can use what has been called the ‘‘postnatal’’ test
(Pennings et al,3). The standard here employed is what would
be acceptable if the donor child already existed. Umbilical
cord blood harvest is widely accepted since it entails physical
intrusions neither on the newborn child, nor on the mother.
There have been discussions about whether early clamping of
the umbilical cord can negatively affect the neonate but this
has been disproved.28 Bone marrow donations from young
children to siblings are also widely accepted. Harvesting vital
organs from children is not acceptable in view of the risks
involved for the donor child. The donation of a kidney
constitutes a difficult borderline case,29 since one can live a
healthy life with one kidney, but, of course, such a life is
never without risks. I will not go deeper into the very
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complex discussion of paediatric living organ donation in this
paper, but would like to mention that one possible approach
is to say that the more risk and inconvenience involved in a
procedure, the closer the relationship between donor and
recipient should be. A kidney donation between two young
siblings would therefore be more justifiable than one
between two siblings growing up in different families. The
reasoning behind this is that there is a potential psychological
benefit for the donor child. A very young child may later on
experience gratification or, when it is not allowed to donate
stem cells or a kidney, a feeling of guilt. Moreover, if the
recipient is—for example, a sibling, the donor child will have
the advantage of growing up in a less stressful family
environment than if the sick child had died. Decisions about
such complex issues should be made on a case by case basis,
the costs and potential benefits should be carefully weighed
up, and the parents should make the decision with the best
interests of their children in mind.
The second concern of opponents of PGD/HLA typing to
create a donor child is whether this technique should be
available when the intended recipient is someone other than
a sibling.
In the Netherlands—for example, a father with leukaemia
was saved by his daughter’s umbilical cord blood30: Pennings
mentions this example.25 In the UK, the HFEA stipulates that
PGD for HLA typing should not be available if the intended
recipient is a parent.31 But why not?
One possible argument for banning these techniques when
the intended recipient is a parent could be that since the
chance of having a tissue matched child is very small (1 in
200), the IVF/PGD treatment is futile (given the extremely
low chance of a successful pregnancy and having a matched
embryo). However, the situation might be more problematic
if bone marrow is needed. Umbilical cord blood stem cells
need not be as closely matched as bone marrow stem cells.
The age, the health status, and the disease of the recipient are
also factors that determine how closely the match needs to
be. Another possible problem is that the number of stem cells
that can be obtained from the cord blood is too small to treat
an adult. Research is, however, being directed toward
overcoming this restriction in order to extend this option to
adult patients.32
A second possible argument is that a conflict of interests
could endanger the life of the child.
This conflict of interests is also present, however, when the
recipient is a sibling.25 First of all, in the case where the
recipient is a parent, it would meet the postnatal test since
bone marrow transplantations from children to their parents
are currently accepted.33 Secondly, as previously said, it is
very unlikely that people who make so much effort to save a
sick child or another loved one, will mistreat the new child.
Thirdly, in liberal countries, the decision to have children is
an area of private life in which the state may only intervene
to prevent serious harms. Consequently in such countries if
there is no reason to think the future child will be harmed,
couples requesting PGD for HLA typing in order to have a
donor child should be allowed to seek the necessary
treatment.
If we know there is a reasonable chance that if a couple has
a baby, stem cells from the cord blood will be used to treat
their desperately sick child, or any other person they want to
help, I do not see any reason to refuse them PGD/HLA typing
to select a matched embryo. The donor child will not be
harmed by the procedure and a desperately sick person can
be saved. Even when there is a chance that, at a later age, a
bone marrow harvest might be needed, this procedure should
be allowed. Research has indicated that the levels of pain
experienced by bone marrow donors are rather low34 and that
the discomfort and psychological maladjustment experienced
by the donor can be reduced through good monitoring.35 36
When the burdens can be kept to a minimum, it should be
up to the parents as guardians of their child to decide
what can be done to their child in order to save another loved
one. It does not matter whether the recipient is family or not.
We sometimes have stronger emotional bonds to people
unrelated to us than to family members. Therefore, we
should not restrict the use of PGD/HLA to siblings, as the
HFEA currently does, but instead should allow people to have
children to help other loved ones as well their existing
children.
5. ALTERNATIVE SCENARIOS
Insurance policy
What should one think of the option of using preimplanta-
tion HLA typing to ensure that all of one’s children will be
HLA identical, in case one of them needs a transplant? This
option has been presented by Pennings.25
On the basis of considerations related to the risks of PGD
and the welfare of the donor child, we have no good reason
to object. We already accept the risks of PGD in order to
benefit people with the desire for a child, and the child
will certainly be created for its own sake, since its use as a
donor is only conditional. Creating an HLAmatched child as a
back up or an insurance policy may, however, be
more difficult to justify because of the costs and effort
required for the procedure. Preimplantation genetic
diagnosis in conjunction with HLA typing is labour intensive
and requires multidisciplinary collaboration.37 The financial
cost is currently very high. If PGD is used to create a child
that can save its sibling, then these costs can be compared
with the probable higher costs related to the use of unrelated
donors or a continued programme of standard medical
treatment with no prospect of a cure (Van de Velde,8 p
706). In the case of pre implantation tissue typing to create a
back up there is no such weighing up to be done. Once the
procedure becomes more routine, however, the effort and
costs would be reduced and this option should be recon-
sidered.
Banking of HLA typed embryos
A valuable option which might be worth exploring as an
alternative to back ups is the banking of HLA typed frozen
embryos to provide a wide range of HLA types for unrelated
individuals in need of compatible stem cells or tissue. One
could adopt the embryo and carry it to term so that an HLA
matched child is born, or one could use the embryo in vitro as
a source of stem cells. Moreover, this option may be more
acceptable for those who accept IVF but oppose therapeutic
cloning.38
6. CONCLUSION
In conclusion, PGD for HLA typing offers the possibility of
having a child that can save a sick sibling. This person
affecting reason for using the procedure is not a reason to
forbid the practice, but, on the contrary, constitutes a strong
argument in favour of it. Since there are no indications that
donor children will be harmed, and we know that some
people will be saved, it would be unethical not to allow this
procedure and not to explore its further potentialities. When
the burdens are minimal, as is usually the case in cord blood
or bone marrow donation, it should be up to the parents to
decide whether their children or their future children can act
as donors for a loved one. This should not be restricted to
siblings and not even to family members. It should be offered
to any couples who decide to have a tissue matched baby that
can save someone whom they love.
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Notice
Ethical aspects of the new genetics: what we all need to know
This one day conference and debate is open to all and will take place at the Cheltenham Town
Hall on Friday 18 November 2005.
Tickets are £10 and are available from Gloucestershire Federation of WI’s, 2 Brunswick
Square, GL1 1UL, tel: 01452 523 966; email: Liz@gfwi.org.uk. For futher information visit
www.gfwi.org.uk
A limited number of free tickets funded by the Institute of Medical Ethics are available to health
care students. Apply with staff confirmation of student status by sending a SAE to Maureen
Bannatyne, Insitute of Medical Ethics, St Chloe, The Avenue, Old Bussage, Glos GL6 8AT.
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